Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Placebo-controlled Randomized Trial of Isoniazid for the Reversion of a Positive IFNg ELISPOT in TB Case Contacts

NCT00130325 is registered in ClinicalTrials.gov with Medical Research Council Unit, The Gambia as lead sponsor.

NCT NCT00130325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00130325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Placebo-controlled Randomized Trial of Isoniazid for the Reversion of a Positive IFNg ELISPOT in TB Case Contacts
Lead sponsor
Medical Research Council Unit, The Gambia
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2004
Completion date
June 30, 2009
Enrollment
214 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis